We further constructed a nomogram model to predict the survival probabilities at 1, 2, and 3 years for patients with HCC, C-index: 0.794 (0.763–0.824) by integrating clinicopathologic factors, including FCGBP expression levels, T stage, M stage, TP53, adjacent hepatic tissue, inflammation, histologic grade, prothrombin time, and status of vascular invasion (Figure 1I). This evidence concerns the gene TP53 and hepatocellular carcinoma.